Skip to main content

Abstract

Aim: The optimal management strategies for spontaneous intracerebral hemorrhage in the basal ganglia region are still controversial. The purpose of the present study is to evaluate the clinical benefits of craniotomy, minimally invasive puncture and drainage (MIPD) and conservative treatment in patients with basal ganglia hematoma. Materials & methods: This study retrospectively enrolled consecutive patients with hematoma ≥20 ml in the basal ganglia hemorrhage and onset to admission within 24 h. Primary outcome was the proportion of favorable outcome (modified Rankin scale score 0–3) at 3 months. Secondary outcomes included excellent outcome (modified Rankin scale score 0–2) and mortality at 3 months and 1 year. Sensitive analysis was performed in patients with hematoma ≥ 30 ml. Results: A total of 481 patients were included and divided into three groups: 146 received craniotomy, 211 underwent MIPD and 124 were managed with conservative treatment. The proportion of primary outcome was lower in the craniotomy (23.24%) than in the MIPD (35.41%) and conservative treatment (41.94%) groups. Among patients with hematoma ≥30 ml, MIPD has higher rates of favorable outcome at 3 months (37.32 vs 25.98%, p = 0.05) and 1 year (52.82 vs 40.16%, p = 0.04) compared with craniotomy; albeit. The short-term and long-term mortality was similar in three groups. Conclusion: MIPD was found to be associated with both short- and long-term favorable outcomes in patients with spontaneous intracerebral hemorrhage in the basal ganglia region. Moreover, neither MIPD nor craniotomy showed an association with increased risk of short- or long-term mortality.

Plain language summary: Which treatment works best for deep brain bleeds: minimally invasive drainage, open surgery or medication-only care?

What is this article about?

Patients with sudden bleeding in deep brain regions (basal ganglia hemorrhage) face high risks of disability. This study compared three treatments: open brain surgery (craniotomy), a less invasive drainage procedure (MIPD) and medication-only care (conservative treatment), to see which best preserves patients' independence.

What were the results?

MIPD was found to be associated with both short- and long-term favorable outcomes in patients with spontaneous intracerebral hemorrhage in the basal ganglia region. Moreover, neither MIPD nor craniotomy showed an association with increased risk of short- or long-term mortality.

Why is this important?

Doctors often debate whether surgery helps deep brain bleeds. This study shows that less invasive options (minimally invasive drainage or careful monitoring) may improve recovery more than open surgery, without increasing death risk. For large bleeds, minimally invasive drainage appears to offer the best chance for independence. These findings could potentially steer treatment toward safer, more effective approaches – especially where resources for complex surgery are limited.

Supplementary Material

File (supplementary material.docx)

References

Papers of special note have been highlighted as: • of interest; •• of considerable interest
1.
Keep RF, Hua Y, Xi G. Intracerebral haemorrhage: mechanisms of injury and therapeutic targets. Lancet Neurol. 11(8), 720–731 (2012).
2.
Krishnamurthi RV, Feigin VL, Forouzanfar MH et al. Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990–2010: findings from the global burden of disease study 2010. Lancet Glob. Health 1(5), e259–e281 (2013).
3.
Mendelow AD, Gregson BA, Fernandes HM et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the international surgical trial in intracerebral haemorrhage (STICH): a randomised trial. Lancet 365(9457), 387–397 (2005).
4.
Krishnamurthi RV, Ikeda T, Feigin VL. Global, regional and country-specific burden of ischaemic stroke, intracerebral haemorrhage and subarachnoid haemorrhage: a systematic analysis of the global burden of disease study 2017. Neuroepidemiology 54(2), 171–179 (2020).
5.
Wang GQ, Li SQ, Huang YH et al. Can minimally invasive puncture and drainage for hypertensive spontaneous basal ganglia intracerebral hemorrhage improve patient outcome: a prospective non-randomized comparative study. Mil. Med. Res. 1, 10 (2014).
• Provided early prospective evidence supporting the use of minimally invasive puncture and drainage (MIPD) in basal ganglia hemorrhage.
6.
Mendelow AD, Gregson BA, Rowan EN et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial. Lancet 382(9890), 397–408 (2013).
•• Landmark randomized controlled trial (STICH II) showing no significant advantage of craniotomy over conservative treatment.
7.
Li Z, Li Y, Xu F et al. Minimal invasive puncture and drainage versus endoscopic surgery for spontaneous intracerebral hemorrhage in basal ganglia. Neuropsychiatr. Dis. Treat. 13, 213–219 (2017).
8.
Hanley DF, Thompson RE, Rosenblum M et al. Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial. Lancet 393(10175), 1021–1032 (2019).
•• Large multicenter randomized clinical trial (RCT) (MISTIE III) providing high-level evidence for minimally invasive hematoma evacuation.
9.
Pradilla G, Ratcliff JJ, Hall AJ et al. Trial of early minimally invasive removal of intracerebral hemorrhage. N. Engl. J. Med. 390(14), 1277–1289 (2024).
• Recent RCT suggesting potential benefits of early minimally invasive removal of ICH.
10.
Fazl A, Fleisher J. Anatomy, physiology, and clinical syndromes of the basal ganglia: a brief review. Semin. Pediatr. Neurol. 25, 2–9 (2018).
11.
Yanagisawa N. Functions and dysfunctions of the basal ganglia in humans. Proc. Jpn Acad. Ser. B Phys. Biol. Sci. 94(7), 275–304 (2018).
12.
Kwak R, Kadoya S, Suzuki T. Factors affecting the prognosis in thalamic hemorrhage. Stroke 14(4), 493–500 (1983).
13.
Greenberg SM, Ziai WC, Cordonnier C et al. 2022 guideline for the management of patients with spontaneous intracerebral hemorrhage: a guideline from the American Heart Association/American Stroke Association. Stroke 53(7), e282–e361 (2022).
•• Authoritative 2022 AHA/ASA guideline summarizing evidence-based management of spontaneous intracerebral hemorrhage.
14.
Cordonnier C, Demchuk A, Ziai W, Anderson CS. Intracerebral haemorrhage: current approaches to acute management. Lancet 392(10154), 1257–1268 (2018).
15.
Zi W, Qiu Z, Li F et al. Effect of endovascular treatment alone vs intravenous alteplase plus endovascular treatment on functional independence in patients with acute ischemic stroke: the DEVT randomized clinical trial. JAMA 325(3), 234–243 (2021).
16.
Fallenius M, Skrifvars MB, Reinikainen M et al. Spontaneous intracerebral hemorrhage. Stroke 50(9), 2336–2343 (2019).
17.
Mould WA, Carhuapoma JR, Muschelli J et al. Minimally invasive surgery plus recombinant tissue-type plasminogen activator for intracerebral hemorrhage evacuation decreases perihematomal edema. Stroke 44(3), 627–634 (2013).
18.
Xu X, Zhang H, Zhang J et al. Minimally invasive surgeries for spontaneous hypertensive intracerebral hemorrhage (MISICH): a multicenter randomized controlled trial. BMC Med. 22(1), 244 (2024).
• Recent multicenter RCT in China evaluating minimally invasive surgery, highly relevant to the study population.
19.
de Oliveira Manoel AL. Surgery for spontaneous intracerebral hemorrhage. Crit. Care 24(1), 45 (2020).
20.
Guo W, Liu H, Tan Z et al. Comparison of endoscopic evacuation, stereotactic aspiration, and craniotomy for treatment of basal ganglia hemorrhage. J. Neurointerv. Surg. 12(1), 55–61 (2020).
• Comparative study exploring different surgical strategies for basal ganglia hemorrhage.
21.
Zhu H, Wang Z, Shi W. Keyhole endoscopic hematoma evacuation in patients. Turk. Neurosurg. 22(3), 294–299 (2012).
22.
Beynon C, Schiebel P, Bosel J et al. Minimally invasive endoscopic surgery for treatment of spontaneous intracerebral haematomas. Neurosurg. Rev. 38(3), 421–428 (2015).
23.
Zhou H, Zhang Y, Liu L et al. Minimally invasive stereotactic puncture and thrombolysis therapy improves long-term outcome after acute intracerebral hemorrhage. J. Neurol. 258(4), 661–669 (2011).
• Demonstrated that minimally invasive stereotactic puncture combined with thrombolysis improved long-term outcomes.
24.
Delcourt C, Sato S, Zhang S et al. Intracerebral hemorrhage location and outcome among INTERACT2 participants. Neurology 88(15), 1408–1414 (2017).